In our previous study, we revealed the diagnostic usefulness of sCD40L evaluation in CRC patients, as the area under the receiver-operator curve (AUC) was 0.915 in differentiating cancer from non-cancer patients [28]. The gene discussed is CD40LG; the disease is cancer.